Please login to the form below
J&J puts pressure on rivals with new Erleada okay in prostate cancer
FDA previously granted priority review in this indication
Bluebird Bio reveals further encouraging data for CALD gene therapy
Study shows continued benefit in treatment of rare disease
Takeda’s HAE drug Takhzyro backed by NICE
New treatment option for rare, hereditary disease
Distribution of Novartis’ generic Zantac halted due to carcinogen concerns
Ranitidine medicines found to contain cancer-causing substance
Roche wins FDA breakthrough for Gazyva in lupus nephritis
Drug originally approved as a lymphoma treatment
Zenopa delivers Communiqué prizes to winners
Publicis Resolute's Georgina Chan, MGP's Peter Sayer and Celgene's Sara Jones win the prizes
Biogen loses another pipeline drug to toxicity concerns
Follows discontinuation of Eisai-partnered Alzheimer's drug
FDA starts speedy review of Merck’s Ebola vaccine
First company to file for approval in the US
Purdue Pharma files for bankruptcy after opioid settlement
Company has faced brunt of blame for fuelling epidemic
Q&A: Jessica Pacey
PME interviews the founder and chief executive of newly launched health comms agency, 67health
-
Who's calling the shots in European healthcare?Patients versus Pharma: industry too powerful, and too cosy with EMA, says Yannis Natsis
-
Q&A with Tim CockroftPME interviews the founding director of akt health communications
-
Novartis eyes potential new indication for CosentyxUnveils positive late-stage results in axial spondyloarthritis
-
Acceleron scraps rare muscular dystrophy drug Clinical profile not strong enough to push into late-stage testing
-
J&J's Tremfya filed for approval in US for psoriatic arthritis Seeking share of increasingly competitive psoriasis market
-
New data backs GeNeuro’s MS drug after Servier exitSearch continues for new development partner
-
Envision Pharma Group relocates to support expansionOffice moves in the US prompted by significant growth
-
Biogen and Eisai drop Alzheimer’s drug elenbecestatLatest blow in string of failures for BACE inhibitor category
-
Aimmune gets FDA panel backing for peanut allergy therapyStep closer to becoming first approved treatment
Latest appointments
-
Life announces two new hiresStrenghtens growing creative department
-
New hires at Bayer, Eisai and Accord HealthcareThe latest movers in pharma
-
New faces at 90TEN, Lucid Group and Porterhouse Latest movers in healthcare comms
-
Senior leadership moves announced at Publicis HealthNew roles will support European operations
-
Lucid Group announces new hires at its creative and digital agency Bluedog Follows group's success at Communiqué 2019
Featured jobs
-
Events Executive
-
DOE
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Manager – Healthcare advertising
-
Salary TBC
-
Senior Medical Writer
-
Competitive salary plus benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Client Services Director- Flexible Working
-
Negotiable
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- AbbVie/Allergan's merger faces public opposition
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Report: Customer experience, shaping digital healthcare
- The benefits of uniting in a divergent environment
- Encouraging signs in biomarker R&D
- J&J puts pressure on rivals with new Erleada okay in prostate cancer
- Pharma exhibition stand design with added value
- Bluebird Bio reveals further encouraging data for CALD gene therapy
PMHub
Skills in Healthcare
At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
